- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 7 residues within 4Å:- Chain A: D.123, N.129, I.130, S.131, N.349, T.351, Q.358
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.131, A:Q.358
NAG-NAG-BMA-MAN-MAN.22: 7 residues within 4Å:- Chain B: D.123, N.129, I.130, S.131, N.349, T.351, Q.358
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.131, B:Q.358
NAG-NAG-BMA-MAN-MAN.42: 7 residues within 4Å:- Chain C: D.123, N.129, I.130, S.131, N.349, T.351, Q.358
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.131, C:Q.358
NAG-NAG-BMA-MAN-MAN.62: 7 residues within 4Å:- Chain D: D.123, N.129, I.130, S.131, N.349, T.351, Q.358
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:S.131, D:Q.358
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 7 residues within 4Å:- Chain A: I.472, N.474, T.476, Q.477, Q.488, F.526, G.531
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 7 residues within 4Å:- Chain B: I.472, N.474, T.476, Q.477, Q.488, F.526, G.531
No protein-ligand interaction detected (PLIP)NAG-NAG.43: 7 residues within 4Å:- Chain C: I.472, N.474, T.476, Q.477, Q.488, F.526, G.531
No protein-ligand interaction detected (PLIP)NAG-NAG.63: 7 residues within 4Å:- Chain D: I.472, N.474, T.476, Q.477, Q.488, F.526, G.531
No protein-ligand interaction detected (PLIP)- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 1 residues within 4Å:- Chain A: N.40
No protein-ligand interaction detected (PLIP)NAG.5: 2 residues within 4Å:- Chain A: S.127, N.129
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.127, A:S.127, A:S.127, A:N.129
NAG.6: 5 residues within 4Å:- Chain A: P.325, Y.326, P.327, N.457
- Ligands: SO4.19
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.326
NAG.24: 1 residues within 4Å:- Chain B: N.40
No protein-ligand interaction detected (PLIP)NAG.25: 2 residues within 4Å:- Chain B: S.127, N.129
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.127, B:S.127, B:S.127, B:N.129
NAG.26: 5 residues within 4Å:- Chain B: P.325, Y.326, P.327, N.457
- Ligands: SO4.39
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.326
NAG.44: 1 residues within 4Å:- Chain C: N.40
No protein-ligand interaction detected (PLIP)NAG.45: 2 residues within 4Å:- Chain C: S.127, N.129
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:S.127, C:S.127, C:S.127, C:N.129
NAG.46: 5 residues within 4Å:- Chain C: P.325, Y.326, P.327, N.457
- Ligands: SO4.59
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.326
NAG.64: 1 residues within 4Å:- Chain D: N.40
No protein-ligand interaction detected (PLIP)NAG.65: 2 residues within 4Å:- Chain D: S.127, N.129
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:S.127, D:S.127, D:S.127, D:N.129
NAG.66: 5 residues within 4Å:- Chain D: P.325, Y.326, P.327, N.457
- Ligands: SO4.79
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:Y.326
- 8 x ZN: ZINC ION(Non-covalent)
ZN.7: 7 residues within 4Å:- Chain A: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.8, PC.20
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:D.232, A:H.379, A:H.411
ZN.8: 6 residues within 4Å:- Chain A: D.160, H.162, D.232, H.413
- Ligands: ZN.7, PC.20
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.160, A:H.162, A:D.232, A:H.413
ZN.27: 7 residues within 4Å:- Chain B: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.28, PC.40
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:D.232, B:H.379, B:H.411
ZN.28: 6 residues within 4Å:- Chain B: D.160, H.162, D.232, H.413
- Ligands: ZN.27, PC.40
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.160, B:H.162, B:D.232, B:H.413
ZN.47: 7 residues within 4Å:- Chain C: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.48, PC.60
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:D.232, C:H.379, C:H.411
ZN.48: 6 residues within 4Å:- Chain C: D.160, H.162, D.232, H.413
- Ligands: ZN.47, PC.60
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:D.160, C:H.162, C:D.232, C:H.413
ZN.67: 7 residues within 4Å:- Chain D: D.160, D.232, N.272, H.379, H.411
- Ligands: ZN.68, PC.80
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:D.232, D:H.379, D:H.411
ZN.68: 6 residues within 4Å:- Chain D: D.160, H.162, D.232, H.413
- Ligands: ZN.67, PC.80
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:D.160, D:H.162, D:D.232, D:H.413
- 44 x SO4: SULFATE ION(Non-functional Binders)
SO4.9: 3 residues within 4Å:- Chain A: H.384, H.411
- Ligands: PC.20
Ligand excluded by PLIPSO4.10: 2 residues within 4Å:- Chain A: K.59, N.62
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain A: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain A: K.141, S.144
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain A: R.102, I.286, E.287, H.290
Ligand excluded by PLIPSO4.14: 6 residues within 4Å:- Chain A: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain A: P.534, S.535, E.536
- Chain D: P.189, A.190
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain A: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain A: R.515, G.516
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain A: D.94
- Ligands: NAG-NAG-BMA.1, NAG-NAG-BMA.1
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain A: D.225, Y.326, N.457
- Ligands: NAG.6
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain B: H.384, H.411
- Ligands: PC.40
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain B: K.59, N.62
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain B: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain B: K.141, S.144
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain B: R.102, I.286, E.287, H.290
Ligand excluded by PLIPSO4.34: 6 residues within 4Å:- Chain B: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain B: P.534, S.535, E.536
- Chain C: P.189, A.190
Ligand excluded by PLIPSO4.36: 4 residues within 4Å:- Chain B: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.37: 2 residues within 4Å:- Chain B: R.515, G.516
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain B: D.94
- Ligands: NAG-NAG-BMA.21, NAG-NAG-BMA.21
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain B: D.225, Y.326, N.457
- Ligands: NAG.26
Ligand excluded by PLIPSO4.49: 3 residues within 4Å:- Chain C: H.384, H.411
- Ligands: PC.60
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain C: K.59, N.62
Ligand excluded by PLIPSO4.51: 3 residues within 4Å:- Chain C: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.52: 2 residues within 4Å:- Chain C: K.141, S.144
Ligand excluded by PLIPSO4.53: 4 residues within 4Å:- Chain C: R.102, I.286, E.287, H.290
Ligand excluded by PLIPSO4.54: 6 residues within 4Å:- Chain C: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.55: 5 residues within 4Å:- Chain B: P.189, A.190
- Chain C: P.534, S.535, E.536
Ligand excluded by PLIPSO4.56: 4 residues within 4Å:- Chain C: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.57: 2 residues within 4Å:- Chain C: R.515, G.516
Ligand excluded by PLIPSO4.58: 3 residues within 4Å:- Chain C: D.94
- Ligands: NAG-NAG-BMA.41, NAG-NAG-BMA.41
Ligand excluded by PLIPSO4.59: 4 residues within 4Å:- Chain C: D.225, Y.326, N.457
- Ligands: NAG.46
Ligand excluded by PLIPSO4.69: 3 residues within 4Å:- Chain D: H.384, H.411
- Ligands: PC.80
Ligand excluded by PLIPSO4.70: 2 residues within 4Å:- Chain D: K.59, N.62
Ligand excluded by PLIPSO4.71: 3 residues within 4Å:- Chain D: Q.86, S.87, H.90
Ligand excluded by PLIPSO4.72: 2 residues within 4Å:- Chain D: K.141, S.144
Ligand excluded by PLIPSO4.73: 4 residues within 4Å:- Chain D: R.102, I.286, E.287, H.290
Ligand excluded by PLIPSO4.74: 6 residues within 4Å:- Chain D: P.537, C.538, G.539, T.540, P.541, C.542
Ligand excluded by PLIPSO4.75: 5 residues within 4Å:- Chain A: P.189, A.190
- Chain D: P.534, S.535, E.536
Ligand excluded by PLIPSO4.76: 4 residues within 4Å:- Chain D: G.516, D.517, M.518, Q.519
Ligand excluded by PLIPSO4.77: 2 residues within 4Å:- Chain D: R.515, G.516
Ligand excluded by PLIPSO4.78: 3 residues within 4Å:- Chain D: D.94
- Ligands: NAG-NAG-BMA.61, NAG-NAG-BMA.61
Ligand excluded by PLIPSO4.79: 4 residues within 4Å:- Chain D: D.225, Y.326, N.457
- Ligands: NAG.66
Ligand excluded by PLIP- 4 x PC: PHOSPHOCHOLINE(Non-covalent)
PC.20: 12 residues within 4Å:- Chain A: D.160, H.162, D.232, H.236, N.272, H.273, H.379, H.411, H.413
- Ligands: ZN.7, ZN.8, SO4.9
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:N.272
- Salt bridges: A:H.162, A:H.236, A:H.273, A:H.411, A:H.413
- pi-Cation interactions: A:H.413
PC.40: 12 residues within 4Å:- Chain B: D.160, H.162, D.232, H.236, N.272, H.273, H.379, H.411, H.413
- Ligands: ZN.27, ZN.28, SO4.29
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:N.272
- Salt bridges: B:H.162, B:H.236, B:H.273, B:H.411, B:H.413
- pi-Cation interactions: B:H.413
PC.60: 12 residues within 4Å:- Chain C: D.160, H.162, D.232, H.236, N.272, H.273, H.379, H.411, H.413
- Ligands: ZN.47, ZN.48, SO4.49
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:N.272, C:N.272
- Salt bridges: C:H.162, C:H.236, C:H.273, C:H.411, C:H.413
- pi-Cation interactions: C:H.413
PC.80: 12 residues within 4Å:- Chain D: D.160, H.162, D.232, H.236, N.272, H.273, H.379, H.411, H.413
- Ligands: ZN.67, ZN.68, SO4.69
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:N.272, D:N.272
- Salt bridges: D:H.162, D:H.236, D:H.273, D:H.411, D:H.413
- pi-Cation interactions: D:H.413
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, Y.F. et al., Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Nat Commun (2016)
- Release Date
- 2016-09-07
- Peptides
- Sphingomyelin phosphodiesterase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x ZN: ZINC ION(Non-covalent)
- 44 x SO4: SULFATE ION(Non-functional Binders)
- 4 x PC: PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, Y.F. et al., Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Nat Commun (2016)
- Release Date
- 2016-09-07
- Peptides
- Sphingomyelin phosphodiesterase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A